September 15, 2022
The University of Cincinnati Gardner Neuroscience Institute is transforming into a Learning Health System, a data-driven, patient-centered approach with the goal of measurably improving outcomes for patients with neurological disorders.
September 29, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society for Radiation Oncology (ASTRO) Annual Meeting, held Oct. 1-4 in San Diego.
February 20, 2024
The University of Cincinnati Cancer Center is the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
June 14, 2024
Dr. Vincent Martin, professor in the UC College of Medicine, presents research at the annual American Headache Society meeting showing that as temperatures rise so do the chances for migraine attacks.
June 28, 2023
Imagine a day when a urine test could inform a doctor precisely why a kidney transplant patient was experiencing organ rejection and suggest the best medication for specifically addressing the problem. That day took a leap closer to reality thanks to a set of single-cell analyses that have identified the most specific cellular signatures to date for kidney transplant rejection. The findings were published in the Journal of Clinical Investigation.
January 11, 2023
How cells shape complex tissues and organs during embryo development, which makes us what we are, has many mysteries. New UC research examines one such process which leads to the formation of vertebral or spinal column.
April 29, 2021
UC research found that some water bottles labeled BPA-free actually contained traces of the chemical and that multiple cycles through the dishwasher was the most effective at removing BPA.
May 13, 2021
Donald Lynch Jr., MD, assistant professor at the University of Cincinnati College of Medicine, will be presenting preliminary research at the American College of Cardiology on Saturday, May 15, that suggests plasma proteins discovered in the blood samples of diabetic patients who went on to develop obstructive coronary disease (OCAD) may serve as biomarkers of severe heart blockage.
June 21, 2021
UC researchers Thomas Thompson, PhD, and Kaitlin Hart, hope to advance our understanding of of the protein anti-Müllerian hormone (AMH), which helps form male reproductive organs and in females regulates follicle development and ovulation in the ovaries. It may someday help us treat infertility in women.